Skip to content

Analysis Solutions

default-logo
Menu
  • Expertise & Lab Services
    • Pharmaceutical Analysis
      • Confocal Raman Microscopy
      • Container Closure Integrity Testing (CCIT)
      • Extractables & Leachables
      • Foreign Particulate & Contamination Analysis
      • Glass Delamination Analysis – Testing Interactions in Drug Products
      • Particle Sizing, Counting, And Identification for Pharmaceutical Products
      • Particulate Matter Database
      • Raw Materials Analysis for Pharmaceuticals
      • Source Determination – Detect the Origins of Contaminants in Drug Products
      • USP 788 and USP 789
    • Materials Analysis
      • Foreign Particulate & Contamination Analysis
      • Metal Cleanliness Testing
      • Raw Materials Analysis
      • Root Cause Analysis
    • Medical Device Analysis
      • Failure & Defect Analysis
      • Infusion Equipment Analysis
      • Materials Characterization
      • Particulate Sizing, Counting & Identification
    • Wear Debris Analysis
    • Failure & Defect Analysis
  • Innovation & Technology
    • ParticleID
    • Real-Time Collaboration
    • Instrumentation & Techniques
    • Our Facility
    • Specialized Sample Preparation
  • Industry Resources
    • Articles & Publications
    • News & Events
    • Posters & Presentations
    • Recorded Webinars
  • Our Company
    • Gateway Service Agreement
    • Accreditations & Certifications
    • Brochures
    • Career Opportunities
  • Contact Us
    • Customer Support
    • Refer Services
    • Quote Request
    • General Inquiry

Evaluating API Heterogeneity in a Multilayered Transdermal Patch

  • Post author:admin
  • Post published:June 26, 2021
  • Post category:Publications
  • Post comments:0 Comments

  Drug release speed is determined by the complex relationships between the polymer matrix used, the layer thickness, membrane permeability, if any, and the content and concentration of drug. When…

Continue ReadingEvaluating API Heterogeneity in a Multilayered Transdermal Patch

Working to Address the FDA Critical Path Opportunity for Generic Nasal Spray Suspensions

  • Post author:admin
  • Post published:June 22, 2021
  • Post category:Webinars
  • Post comments:0 Comments

Download our webinar on working to address the FDA critical path opportunity for generic nasal spray suspensions.

Continue ReadingWorking to Address the FDA Critical Path Opportunity for Generic Nasal Spray Suspensions

We're Here to Build Relationships!

Providing specialized support for accelerating your pharmaceutical product's journey to market!

Contact Us Today
default-logo

Gateway Analytical LLC.
2009 Kramer Rd.
Gibsonia, PA 15044
Tel: +1 (724) 443-1900
info@gatewayanalytical.com

OUR EXPERTISE

Pharmaceutical Analysis

Medical Device Analysis

Materials Analysis

INNOVATION / TECH

Our Facility

Instrumentation & Techniques

Specialized Sample Preparation

ParticleID

RESOURCES / NEWS

Articles & Publications

Posters & Presentations

Recorded Webinars

Brochures

COMPANY

Accreditations & Certifications

Gateway Service Agreement

Career Opportunities

©2023 Gateway Analytical. All Rights Reserved. | Terms & Conditions

Linkedin Twitter Youtube Slideshare